Clinical Trials in Dallas

Showing 5381-5400 of 17,468 trials

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk

NCT03825588

In this 2-site study, University of Texas Southwestern Medical Center (UTSW) and Western Psychiatric Institute and Clinic (WPIC), the investigators will conduct a randomized clinical trial (RCT) in 240 psychiatrically hospitalized suicidal adolescents, examining the single and additive effects of two components of an inpatient unit intervention for suicidal adolescents, As Safe As Possible (ASAP), which focuses on emotion regulation and safety planning, and an emotion regulation/safety plan phone app (BRITE).

Suicidal IdeationSuicide, Attempted

University of Texas Southwestern Medical Center241 participantsStarted Apr 2019

Pittsburgh, Pennsylvania, United States • Dallas, Texas, United States

Active Not RecruitingPhase 3< 1 mile

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

NCT05338970

Disease progression is typical for patients with epidermal growth factor receptor mutated (EGFRm) non-small cell lung cancer (NSCLC). Standard platinum-based chemotherapy offers limited efficacy and an unfavorable safety profile.There is an urgent need for more effective and tolerable therapies for patients with EGFRm NSCLC who have exhausted available targeted therapies. Clinical evidence suggest that patritumab deruxtecan constitutes a promising investigational therapy for patients with EGFRm NSCLC.

Nonsquamous Non-small Cell Lung CancerEGFR L858REGFR Exon 19 Deletion

Daiichi Sankyo586 participantsStarted Jul 2022

Anchorage, Alaska, United States • Springdale, Arkansas, United States • Duarte, California, United States +179 more locations

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Find Trials by Condition in Dallas

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

PhII ICb With/Without Erbitux in MBC Pts

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Get With the Guidelines-Stroke Registry

The INSPIRE-ASP PNA Trial

The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Plasma Resuscitation Without Lung Injury

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults